MedPath

A study to check the effect of Useful Bacteria on Caries causing Microorganisms in Saliva and Plaque of Children

Phase 2
Completed
Conditions
Healthy
Registration Number
CTRI/2017/07/009072
Lead Sponsor
Unique Biotech Ltd
Brief Summary

This study is a randomized, double blind, parallel group, uni-centre placebo controlled trail to evaluate the effect of 1 billion and 2 billion counts of *Bacillus Coagulans* daily for 14 days on pH, levels of Mutans Streptococci and Lactobacilli in saliva and plaque that will be conducted in India. The primary outcome will be the reduction of the levels of Mutans Streptococci and Lactobacilli and neutralisation of pH in saliva and plaque.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Had not taken antibiotic or probiotic in any form within 2 weeks prior to the study.
  • Who are willing to chew the tablet and participate in the study.
Exclusion Criteria
  • Children with acute infections, systemic diseases, immune-compromising conditions and special children.
  • Those who are not willing to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in levels of Mutans Streptococci, Lactobacilli and change in pH of saliva and plaque6 Months
Secondary Outcome Measures
NameTimeMethod
No change in levels of Mutans Streptococci, Lactobacilli and change in pH of saliva and plaque6 Months

Trial Locations

Locations (1)

SVS Institute of Dental Sciences

🇮🇳

Mahbubnagar, ANDHRA PRADESH, India

SVS Institute of Dental Sciences
🇮🇳Mahbubnagar, ANDHRA PRADESH, India
Dr Surendra Reddy Munnangi
Principal investigator
9885148981
surendra.mds@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.